Youth with substance abuse and comorbid mental health disorders

Current Psychiatry Reports

Volumn 10, Issue 3, 2008, Pages 265-271

  Lamps, Christopher A ^b   Sood, Aradhana B ^a   Sood, Rishi ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; AMFEBUTAMONE; ATOMOXETINE; CLOZAPINE; DISULFIRAM; FLUOXETINE; LISDEXAMFETAMINE; LITHIUM; METHYLPHENIDATE; NICOTINE; PLACEBO;

ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD HEALTH; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; COMMUNITY CARE; COMORBIDITY; CULTURAL FACTOR; DEPRESSION; DRUG DEPENDENCE; FAMILY THERAPY; HEALTH CARE COST; HEALTH PROGRAM; HEREDITY; HUMAN; MENTAL DISEASE; MOTIVATION; PHENOMENOLOGY; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCHOOL HEALTH SERVICE; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TOBACCO DEPENDENCE;

ADOLESCENT; COMORBIDITY; HUMANS; MENTAL DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 49249105436     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0043-0     Document Type: Article

References (55)

1. Volkow ND: The reality of comorbidity: depression and drug abuse. Biol Psychiatry 2004, 56:714-717.
2. NIDA InfoFacts: High School and Youth Trends. National Institute on Drug Abuse website. http://www.drugabuse.gov/Infofacts/ HSYouthtrends.html. Accessed February 22, 2008.
3. Drug Use Among Racial/Ethnic Minorities (Revised). National Institute on Drug Abuse website. http://www.drugabuse.gov/pdf/minorities03.pdf. Accessed February 22, 2008.
4. Deas D: Adolescent substance abuse and psychiatric comorbidities. J Clin Psychiatry 2006, 67:18-23.
5. Kaminer Y, Connor D, Curry J: Comorbid adolescent substance use and major depressive disorders. Psychiatry (Edgemont) 2007, 4:32-43. http://www.psychiatrymmc.com/ comorbid-adolescent-substance-use-and-major-depressive-disorders. Accessed April 1, 2008.
6. Deas-Nesmith D, Campbell S, Brady KT: Substance use disorder in an adolescent inpatient psychiatric population. J Natl Med Assoc 1998, 90:233-236.
7. Santosh PJ, Mijovic A: Does pervasive developmental disorder protect children and adolescents against drug and alcohol use? Eur Child Adolesc Psychiatry 2006, 15:183-188.
8. Cornelius JR, Maisto SA, Martin CS, et al.: Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav 2004, 29:1035-1038.
9. Grella CE, Hser YI, Joshi V, et al.: Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 2001, 189:384-392.
10. Libby AM, Riggs PD: Integrated substance use and mental health treatment for adolescents: aligning organizational and financial incentives. J Child Psychopharmacol 2005, 15:826-834.
11. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 2005, 44:609-621.
12. Van Hook S, Harris SK, Brooks T, et al.: The "six T's": barriers to screening teens for substance abuse in primary care. J Adolesc Health 2007, 40:456-461.
13. Halpern-Felsher BL, Ozer EM, Millstein SG, et al.: Preventive services in a health maintenance organization: how well do pediatricians screen and educate adolescent patients? Arch Pediatr Adolesc Med 2000, 154:173-179.
14. Schindler A, Thomasius R, Sack PM, et al.: Insecure family bases and adolescent drug abuse: a new approach to family patterns of attachment. Hum Behav 2007, 9:111-126.
15. Hawkins JD, Catalano RF, Miller JY: Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 1992, 112:64-105.
16. Wilens TE, Biederman J: Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol 2006, 20:580-588.
17. Armstrong TD, Costello EJ: Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. J Consult Clin Psychol 2002, 70:1224-1239.
18. Rao U: Links between depression and substance abuse in adolescents: neurobiological mechanisms. Am J Prev Med 2006, 31(Suppl 1):S161-S174.
19. McQuown SC, Belluzzi JD, Leslie FM: Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicol Teratol 2007, 29:66-73.
20. Degenhardt L, Hall W: The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 2001, 31:659-668.
21. Pollock NK, Martin CS: Diagnostic orphans: adolescents with alcohol symptoms who do not qualify for DSM-IV abuse and dependence diagnoses. Am J Psychiatry 1999, 156:897-901.
22. Kaufman J, Birmaher B, Brent D, et al.: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997, 36:980-988.
23. Winters KC: Assessment of Alcohol and Other Drug Use Behaviors Among Adolescents. National Institute on Alcohol Abuse and Alcoholism website. http://pubs.niaaa.nih.gov/publications/Assesing%20Alcohol/ behaviors.htm. Accessed February 22, 2008.
24. McConnaughy EA, Prochaska JO, Velicer WF: Stages of change in psychotherapy: measurement and sample profiles. Psychother-Theor Res 1983, 20:368-375. http://doi.apa.org.proxy.library.vcu.edu/?uid=1984-11195-001. Accessed April 1, 2008.
25. Faries DE, Yalcin I, Harder D, Heiligenstein JH: Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord 2002, 5:107-115.
26. Waschbusch DA, Elgar FJ: Development and validation of the Conduct Disorder Rating Scale. Assessment 2007, 14:65-74.
27. Myers K, Winters NC: Ten year review of rating scales. II: Scales for Internalizing Disorders. J Am Acad Child Adolesc Psychiatry 2002, 41:634-659.
28. Riggs P: Evidence-based integrated treatment model for co-occurring disorders: Encompass: integrated treatment for adolescents and young adults. Paper presented at the COSIG Training Presentation. Pittsburgh, PA; January 17, 2008.
29. Rollnick S, Miller WR: What is motivational interviewing? Behav Cogn Psychoth 1995, 23:325-334. http://cat.inist.fr/ ?aModele=afficheN&cpsidt=2924065. Accessed April 1, 2008.
30. Tier QQ, Mausbach B: Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res 2007, 31:513-536.
31. Monti PM, Barnett NP, Colby SM, et al.: Motivational interviewing versus feedback only in emergency care for young adult problem drinking. Addiction 2007, 102:1234-1243.
32. Cornelius JR, Clark DB: Depressive disorders. In Psychiatric Comorbidity and High-Risk Behaviors. Edited by Kaminer Y, Bukstein OG. New York: Haworth Press; 2007:221-242.
33. Riggs P, Klein C, Sood AB, et al.: Clinical perspectives 8 - research to practice: adopting an integrated treatment model for adolescents. Paper presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Boston; October 25, 2007.
34. Breslin KT, Reed MR, Malone SB. An holistic approach to substance abuse treatment. J Psychoactive Drugs 2003, 35:247-251.
35. Cohen JA, Mannarino AP, Zhitova AC, et al.: Treating child abuse-related posttraumatic stress and comorbid substance abuse in adolescents. Child Abuse Negl 2003, 27:1345-1365.
36. Myrick H, Cluver J, Swavely S, Peters H: Diagnosis and treatment of co-occurring affective disorders and substance use disorders. Psychiatr Clin North Am 2004, 27:649-659.
37. Nace EP, Birkmayer F, Sullivan MA, et al.: Socially sanctioned coercion mechanisms for addiction treatment. Am J Addict 2007, 16:15-23.
38. Prochaska JO: Assessing how people change. Cancer 1991, 67:805-807.
39. Slesnick N, Prestopnik JL: Ecologically based family therapy outcome with substance abusing runaway adolescents. J Adolesc 2005, 28:277-298.
40. Dishion T, Kavanagh K, Schneiger AK, et al.: Preventing early adolescent substance use: a family centered strategy for the public middle school. Prev Sci 2002, 3:191-202.
41. Geller B, Cooper TB, Sun K, et al.: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998, 37:171-178.
42. Riggs PD, Mikulich-Gilbertson SK, Davies RD, et al.: A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med 2007, 161:1026-1034.
43. Brunette MF, Drake RE, Xie H, et al.: Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophr Bull 2006, 32:637-643.
44. Wilens TE, Gignac M, Swezey A, et al.: Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 2006, 45:408-414.
45. Wilens TE, Adamson J, Sgambati S, et al.: Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict 2007, 16(Suppl 1):14-21.
46. Katusic SK, Barbaresi WJ, Colligan RC, et al.: Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 2005, 15:764-776.
47. Levin FR, Evans SM, Brooks DJ, et al.: Treatment of cocaine dependent treatment seekers with adult ADHD: double blind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007, 87:20-29.
48. Niederhofer H, Staffen W: Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev 2003, 22:295-297.
49. Niederhofer H, Staffen W: Acamprosate and its efficacy in treating alcohol dependent adolescents. Eur Child Adolesc Psychiatry 2003, 12:144-148.
50. Waxmonsky JG, Wilens TE: Pharmacotherapy of adolescent substance abuse disorders: a review of the literature. J Child Adolesc Psychopharmacol 2005, 15:810-825.
51. Spoth R, Guyull M, Day S: Universal family-focused interventions in alcohol-use disorder prevention: cost effectiveness and cost-benefit analyses of two interventions. J Stud Alcohol 2002, 63:219-228.
52. Preventing Drug Abuse Among Children and Adolescents. National Institute on Drug Abuse website. http://www.nida.nih.gov/prevention/ resources.html. Accessed February 22, 2008.
53. Hawkins JD, Graham JW, Maguin E, et al.: Exploring the effects of age of alcohol initiation and psychosocial risk factors on subsequent alcohol misuse. J Stud Alcohol 1997, 58:280-290.
54. Chou C, Montgomery S, Pentz M, et al.: Effects of a community-based prevention program in decreasing drug use in high-risk adolescents. Am J Public Health 1998, 88:944-948.
55. Palmgreen P, Donohew L, Lorch EP, et al.: Television campaigns and adolescent marijuana use: tests of sensation seeking targeting. Am J Public Health 2001, 91:292-296.